These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34000920)

  • 1. MTHFR 677T-1298C haplotype in acute lymphoblastic leukemia: Impact on methotrexate therapy.
    Frikha R; Elloumi M; Rebai T; Kamoun H
    J Oncol Pharm Pract; 2022 Jul; 28(5):1031-1034. PubMed ID: 34000920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of C677T MTHFR variant but not A1298C in methotrexate-induced toxicity in acute lymphoblastic leukemia.
    Frikha R; Jemaa MB; Frikha F; Turki I; Elloumi M; Keskes L; Kamoun H; Rebai T
    J Oncol Pharm Pract; 2021 Sep; 27(6):1382-1387. PubMed ID: 32865163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional variants of gene encoding folate metabolizing enzyme and methotrexate-related toxicity in children with acute lymphoblastic leukemia.
    Kałużna E; Strauss E; Zając-Spychała O; Gowin E; Świątek-Kościelna B; Nowak J; Fichna M; Mańkowski P; Januszkiewicz-Lewandowska D
    Eur J Pharmacol; 2015 Dec; 769():93-9. PubMed ID: 26528799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of methylenetetrahydrofolate reductase gene polymorphisms on toxicities during consolidation therapy in pediatric acute lymphoblastic leukemia in a Chinese population.
    Liu SG; Li ZG; Cui L; Gao C; Li WJ; Zhao XX
    Leuk Lymphoma; 2011 Jun; 52(6):1030-40. PubMed ID: 21534867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The methylenetetrahydrofolate reductase 677T-1298C haplotype is a risk factor for acute lymphoblastic leukemia in children.
    Kałużna EM; Strauss E; Świątek-Kościelna B; Zając-Spychała O; Gowin E; Nowak JS; Rembowska J; Januszkiewicz-Lewandowska D
    Medicine (Baltimore); 2017 Dec; 96(51):e9290. PubMed ID: 29390492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between the methylenetetrahydrofolate reductase gene polymorphisms and haplotype with toxicity response of high dose methotrexate chemotherapy].
    Liao QC; Li XL; Liu ST; Zhang Y; Li TY; Qiu JC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Jul; 33(7):735-9. PubMed ID: 22968027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between MTHFR C677T and A1298C polymorphisms and risk of childhood acute lymphoblastic leukemia in the Kurdish population from Western Iran.
    Azhar MR; Rahimi Z; Vaisi-Raygani A; Akramipour R; Madani H; Rahimi Z; Parsian A
    Genet Test Mol Biomarkers; 2012 Mar; 16(3):198-202. PubMed ID: 22017305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylene tetrahydrofolate reductase genotypes frequencies: association with toxicity and response to methotrexate in rheumatoid arthritis patients.
    Saleh MM; Irshaid YM; Mustafa KN
    Int J Clin Pharmacol Ther; 2015 Feb; 53(2):154-62. PubMed ID: 25492850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Folate-Related Gene Polymorphisms on High-Dose Methotrexate-Related Toxicity and Prognosis in Turkish Children with Acute Lymphoblastic Leukemia.
    Yazıcıoğlu B; Kaya Z; Güntekin Ergun S; Perçin F; Koçak Ü; Yenicesu İ; Gürsel T
    Turk J Haematol; 2017 Jun; 34(2):143-150. PubMed ID: 27094381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma.
    Kantar M; Kosova B; Cetingul N; Gumus S; Toroslu E; Zafer N; Topcuoglu N; Aksoylar S; Cinar M; Tetik A; Eroglu Z
    Leuk Lymphoma; 2009 Jun; 50(6):912-7. PubMed ID: 19391036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia.
    Mahmoud LB; Mdhaffar M; Frikha R; Ghozzi H; Hakim A; Sahnoun Z; Elloumi M; Zeghal K
    Adv Clin Exp Med; 2018 Aug; 27(8):1061-1068. PubMed ID: 29911750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses.
    Urano W; Taniguchi A; Yamanaka H; Tanaka E; Nakajima H; Matsuda Y; Akama H; Kitamura Y; Kamatani N
    Pharmacogenetics; 2002 Apr; 12(3):183-90. PubMed ID: 11927833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia.
    El-Khodary NM; El-Haggar SM; Eid MA; Ebeid EN
    Med Oncol; 2012 Sep; 29(3):2053-62. PubMed ID: 21644011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-versus-host disease following hematopoietic cell transplantation for chronic myelogenous leukemia.
    Robien K; Bigler J; Yasui Y; Potter JD; Martin P; Storb R; Ulrich CM
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):973-80. PubMed ID: 16920564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis.
    Yang L; Hu X; Xu L
    Tumour Biol; 2012 Oct; 33(5):1445-54. PubMed ID: 22528943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetic Variants in MTHFR Gene are Significant Predictors of Methotrexate Toxicities in Bangladeshi Patients With Acute Lymphoblastic Leukemia.
    Zahra FT; Nahid NA; Islam MR; Al-Mamun MMA; Apu MNH; Nahar Z; Kabir AL; Biswas SK; Ahmed MU; Islam MS; Hasnat A
    Clin Lymphoma Myeloma Leuk; 2020 Feb; 20(2):e58-e65. PubMed ID: 31884153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population distribution of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C risk alleles for methotrexate toxicity in Israel.
    Efrati E; Elkin H; Nahum S; Krivoy N
    Rheumatol Int; 2013 Apr; 33(4):1001-4. PubMed ID: 22847291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of Methylenetetrahydrofolate reductase C677T in younger acute lymphoblastic leukemia patients: A single-center experience.
    Frikha R; Rebai T; Lobna BM; Frikha F; Mdhaffar M; Frikha I; Elloumi M; Bouayed N
    J Oncol Pharm Pract; 2019 Jul; 25(5):1182-1186. PubMed ID: 30545275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate-related toxicity in adult acute lymphoblastic leukaemia.
    Eissa DS; Ahmed TM
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):181-8. PubMed ID: 23183238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants.
    D'Angelo V; Ramaglia M; Iannotta A; Crisci S; Indolfi P; Francese M; Affinita MC; Pecoraro G; Napolitano A; Fusco C; Oreste M; Indolfi C; Casale F
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1339-46. PubMed ID: 21590445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.